XORI Corp. is a development stage company focused on a technology for the rapid discovery and development of therapeutic monoclonal antibodies for oncology, immune disorders and infectious disease.
Company (Alive / Active)
1616 Eastlake Ave. E.
Washington, United States
|Investor||Investor Type||Location||Participating Rounds|
|South San Francisco, California, United States||IPO / Went public||Five Prime Therapeutics is a clinical-stage biotechnology company with a pipeline of antibodies and ligand traps for cancer, autoimmunity and respiratory diseases. FivePrime has differentiated discovery capabilities built on its library of secreted and extracellular human proteins, which it leverages in cell-based assays, in vivo models and receptor-ligand matching screens to identify medically relevant new targets and therapeutic proteins. FivePrime has entered into a collaboration agreement to...Show all||Login to see details|
|South San Francisco, California, United States||IPO / Went public||Sunesis is an oncology company developing cell-cycle inhibitors with a method of discovering drugs in pieces, or fragments. This Tethering is a process whereby the fragment is built out using the target protein's surface as a template to make a new full-size therapeutic compound. Per the company, they have developed collaborations with Biogen Idec, Johnson & Johnson PRD and Merck.||Login to see details|
|Title||Application Date||Patent Date||Status
(Patent / Application)